Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Apr;26(2):93-5.
doi: 10.5455/msm.2014.26.93-95. Epub 2014 Apr 11.

Influence of Body Weight on the Biochemical Indicators in Menopause

Free PMC article

Influence of Body Weight on the Biochemical Indicators in Menopause

Muhamed Rosic et al. Mater Sociomed. .
Free PMC article


Introduction: One of the problems of today and probably this century is obesity, which is classified by the WHO as a disease.

Material and methods: We performed a prospective cross-sectional study of the body weight impact on certain biochemical indicators in menopausal women living in the municipalities Cazin and Velika Kladusa.

Results and discussion: The study included 334 women aged 40-60 years, who had regular medical examinations. For each patient at the beginning of the study we measured: body mass index, total cholesterol values, LDL, HDL and triglycerides fractions. Our findings indicate an increase in total cholesterol, LDL fraction and triglycerides in patients with increased body mass index, without statistical significance. Values of HDL fraction were significantly decreased with increasing body mass index.

Keywords: biochemical indicators; body mass index; menopause.

Conflict of interest statement



Figure 1
Figure 1
Arithmetic mean of the observed variables tested in our sample

Similar articles

See all similar articles


    1. Grodstein F, Manson JE, Colditz GA, Willet WC, Speizer FE, Stampfer MJ. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular diseases. Ann Intern Med. 2000;133:933–941. - PubMed
    1. Genazzani AR, Gambacciani M. Controversial issues in climacteric medicine: Cardiovascular disease and hormone replacement therapy. Climacteric. 2000;3:233–240. - PubMed
    1. Mosca L, Collins P, Herrington DM, Mendelsohn M, Pasternak R, Robertson RM, Schenk-Gustafson K, Smith S, Taubert K, Wenger N. Hormone Replacement therapy and Cardiovascular disease. A statement for health-care Comminings SR, Ecker S, Kruger KA et al. The efect of raloxifene on risik of breast cancer in postmenopausal women. Results from the MORE randomized trial. J Am Med Assoc. 1999;281:2189–2197.
    1. Lovrenčić-Huzjan A, Bosnar M, Huzjan R, Demarin V. Frequency of different risk factors for ischemic stroke. Acta clinica Croatica. 2000;38:159–163.
    1. Professionals from the American Heart Association. Circulation. 2001;104:499–503. - PubMed

LinkOut - more resources